Lung metastasectomy became a promising surgical approach to treat different types of cancer. It is believed nowadays that lung localization, after radical removal of the primitive neoplasm, is not to be considered a systemic spread of cancer, but somewhat we can define” organ disease”. So the question is not to use a local therapy to treat a systemic disease but to treat radically an organ with the disease. According to most of the Authors, overall survival in our series is 37% at 5 years. No mortality nor perioperative morbidity has been reported. Most of our interventions were open access, both because of gross disease both to feel lesions. Surgery for lung metastases is safe and should be planned within a multidisciplinary approach because the benefit of such an aggressive surgery is limited to selected subgroups of patients only.
Select your language of interest to view the total content in your interested language